Large-scale testing (Phase 3)Study completedNCT00236431
What this trial is testing
Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
Who this might be right for
DementiaAlzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,063